Adherence and weight loss with a total diet replacement programme for increased cancer risk associated with obesity: a UK cohort study.
To evaluate engagement and weight loss with a 12-month total diet replacement (TDR) programme in women with increased risk of breast and endometrial cancer, living with obesity.
Prospective cohort study.
Secondary care.
47 premenopausal women living with obesity.
12-month programme including a 12-week TDR phase with biopsies of the breast and endometrium, before and after, followed by 4 weeks of diet reintroduction and a weight maintenance/continued weight loss phase (weeks 17-52).
This paper reports retention and adherence to the programme, weight loss, changes in mental well-being, quality of life (QoL), weight loss self-efficacy, physical activity and fidelity of delivery of the programme.
37 women (79%) completed the whole programme. Completers and those who withdrew, respectively, had a mean (SD) age of 41.4 years (5.7) vs 38.1 (5.8) and baseline body mass index of 36.2 (4.9) kg/m2 vs 40.0 (7.9) kg/m2 and 76% vs 90% had children 18 or younger living at home. Median (IQR) weight was reduced at all time points; -10.8 kg (-13.8, -7.2) at 3 months, -11.5 kg (-15, -7.6) at 6 months, -11.0 kg (-16.4, -7.8) at 9 months and -8.4 kg (-13.9, -3.7) at 12 months. Across the 12-month programme, the median (IQR) contacts with the study dietitians per participant was 28 (25, 33) and median contact hours were 7.6 (6.6, 10.6). 68% received psychological support. QOL improved; OWL-QOL (Obesity and Weight Loss)-17 (-24.8, -7.8) and EQ5D 1 (0, 2), with reductions in binge eating scores -4 (-6.5, -0.8) but no changes in mental health or physical activity scales.
TDR could be a weight loss programme for women at increased risk of breast and endometrial cancers related to obesity. Future controlled trials with extended follow-up are required before recommending routine implementation of TDR in high-risk clinics.
ISRCTN15358157.
Prospective cohort study.
Secondary care.
47 premenopausal women living with obesity.
12-month programme including a 12-week TDR phase with biopsies of the breast and endometrium, before and after, followed by 4 weeks of diet reintroduction and a weight maintenance/continued weight loss phase (weeks 17-52).
This paper reports retention and adherence to the programme, weight loss, changes in mental well-being, quality of life (QoL), weight loss self-efficacy, physical activity and fidelity of delivery of the programme.
37 women (79%) completed the whole programme. Completers and those who withdrew, respectively, had a mean (SD) age of 41.4 years (5.7) vs 38.1 (5.8) and baseline body mass index of 36.2 (4.9) kg/m2 vs 40.0 (7.9) kg/m2 and 76% vs 90% had children 18 or younger living at home. Median (IQR) weight was reduced at all time points; -10.8 kg (-13.8, -7.2) at 3 months, -11.5 kg (-15, -7.6) at 6 months, -11.0 kg (-16.4, -7.8) at 9 months and -8.4 kg (-13.9, -3.7) at 12 months. Across the 12-month programme, the median (IQR) contacts with the study dietitians per participant was 28 (25, 33) and median contact hours were 7.6 (6.6, 10.6). 68% received psychological support. QOL improved; OWL-QOL (Obesity and Weight Loss)-17 (-24.8, -7.8) and EQ5D 1 (0, 2), with reductions in binge eating scores -4 (-6.5, -0.8) but no changes in mental health or physical activity scales.
TDR could be a weight loss programme for women at increased risk of breast and endometrial cancers related to obesity. Future controlled trials with extended follow-up are required before recommending routine implementation of TDR in high-risk clinics.
ISRCTN15358157.
Authors
Clarke Clarke, Lombardelli Lombardelli, Barrett Barrett, Wisely Wisely, Sellers Sellers, Issa Issa, Howell Howell, Davidson Davidson, Howell Howell, Harvie Harvie
View on Pubmed